Article Details
Retrieved on: 2018-02-15 07:22:41
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
<div>Davis Polk is advising Roche on its $1.9 billion acquisition of <b>Flatiron Health</b>, Inc. The transaction, which is expected to close in the first half of 2018, is subject to customary closing conditions. Roche is a global pioneer in pharmaceuticals and diagnostics focused on advancing science to improve ...</div>
Article found on:
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here